Hunter syndrome (mucopolysaccharidosis type II) is a recessive X-linked disorder due to mutations in the iduronate 2-sulfatase (IDS) gene encoding a lysosomal iduronate 2-sulfatase.
First Study of prevalence and risk factors for abdominal wall hernia in the Central Russian population
Medical history of 10 > years was taken and clinical examination was performed for residents of Kryukovo rural community (Central Russia). Abdominal wall hernias have been found in 20.9% of population, including 298 men and 485 women (mean age 49.3).
Study of natalizumab treatment of multiple sclerosis in Russia
Natalizumab (NTZ) is approved in Russia for the treatment of highly active relapsing remitting multiple sclerosis and is reimbursed via federal budget program.
Participation in randomised, open-label, phase 3 trial of the combination for treatment of multiple myeloma
Pirogov Medical University has took a part in the international randomised, open-label, phase 3 trial of the combination of pomalidomide, bortezomib, and dexamethasone for treatment of multiple myeloma.
Lecture “The Continuing Need for Useless Knowledge” of Prof. Martin Chalfie
On April 22, Nobel Prize Winner Professor Martin Chalfi of Columbia University (USA) held a lecture “The Continuing Need for Useless Knowledge” at our University. The famous scientist talked about how scientific discoveries are made, and how the...